Coloplast axed traditional budgeting process: "It wasn't promoting growth"

The Covid-19 pandemic has shown that the budgeting process can quickly become redundant. A lesson Coloplast had already learned from the financial crisis.

"We concluded that there was a massive amount of resources being wasted across the organisation as a result our model," Executive BVVP and CFO Anders Lonning-Skovgaard says of the traditional budgeting process. | Photo: Niels Hougaard/ERH

Before 2009, Coloplast's budgeting process often took up to half a year, seizing the time and effort of countless key people in the organization.

Several hundreds of Coloplast leaders met every yet in an auditorium in north of Copenhagen to tune budget constraints. Everybody had to assess how much money their individual unit was going to spend – on everything from HR to financing – every month for the next 12 months. Thousands of fields in forms were filled by function, region and country.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Coloplast upgrades growth expectations following acquisition

Medtech firm Coloplast’s Q1 report for 2021/2022 brings a slight upward adjustment of the reported revenue growth outlook due to foreign exchange developments. Coloplast’s acquisition of Atos Medical is expected to contribute around 6 percent to organic growth.

Demant's surgical division loses president of 13 years

Oticon Medical, the implants division at hearing group Demant, is saying goodbye to President Jes Olsen, who is exiting his role in March after having spearheaded the business leg since 2008. Demant CEO Søren Nielsen is stepping in temporarily until a replacement is found.

Hearing aid market in US grew by 37 percent in 2021

Hearing aid manufacturers have had a good year following one of the worst in their recorded history, as sales in the US have gone up by 37 percent. The progress is mainly driven by the recovery of independent retailers, whereas public sales channel Veterans Affairs still lags behind.

Further reading

Related articles

Latest news

See all jobs